Press "esc" to clear
Go to Advanced Search

Showing results

4150 of 2527
  • Embargo expired:
    8-Aug-2018 8:00 AM EDT

Article ID: 698614

Proof-of-Concept Technique Makes Nanoparticles Attractive for New Medications

University of Utah Health

Researchers at University of Utah Health developed a proof-of-concept technology using nanoparticles that could offer a new approach for oral medications.

Released:
6-Aug-2018 3:00 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Percent-seizure-freedom2_A07DCEF0-965B-11E8-848C141877632E8F.png

Article ID: 698684

Meet the New Drug, Same as the Old Drug: Influx of New Epilepsy Medications Has Not Improved Outcomes

International League Against Epilepsy

In the past three decades, more than 15 new drugs have been approved to treat seizures. Yet data from a longitudinal, single-center study show that people with epilepsy are no more likely to find success with new drugs as they did with older ones.

Released:
7-Aug-2018 4:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 698668

A Scientific Dating Game: Biologists Play RNA-Protein Matchmakers

University of Texas at Dallas

Virtually all functions in our bodies require precise interactions between radically different types of molecules. Researchers at The University of Texas at Dallas are pursuing what differentiates a fruitful encounter from a dud.

Released:
7-Aug-2018 2:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 698664

Smartphones act as digital security blankets in stressful social situations

University of California, Irvine

Not only can your smartphone serve as your wallet, watch and map, it can also be your digital security blanket. In a new study led by the University of California, Irvine, researchers found that when people are in awkward social situations, having their phones with them offers comfort and helps relieve feelings of isolation.

Released:
7-Aug-2018 1:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Social and Behavioral Sciences

Encalada6.jpg

Article ID: 698656

Researchers Look to Worms for a New Model of a Peripheral Nervous System Disease

Scripps Research Institute

"In humans, being able to tweak levels of TTR degradation could act as a means of stopping TTR toxicity."

Released:
7-Aug-2018 12:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 698643

American Society of Anesthesiologists Named Best and Brightest Company to Work For® in Chicago Second Year in a Row

American Society of Anesthesiologists (ASA)

The American Society of Anesthesiologists (ASA) announced that for a second consecutive year, it has been named a winner in the 2018 Chicago Best and Brightest Companies to Work For® in the Medium Business, 101-300 Employees category. Only companies that distinguish themselves as having the most innovative and thoughtful human resources approach receive this honor.

Released:
7-Aug-2018 11:30 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
SalmanHuda1A.jpg

Article ID: 698649

First In-Human Clinical Trial Targeting CD4 Protein for Aggressive T-cell Leukemia and Lymphoma to be Launched

Stony Brook University

Stony Brook University, iCell Gene Therapeutics and University of Louisville collaborate to offer a new CAR T immunotherapy to treat patients.

Released:
7-Aug-2018 11:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
  • Embargo expired:
    7-Aug-2018 11:00 AM EDT

Article ID: 698545

Research Identifies New Treatment Targets in Breast Cancer

Huntsman Cancer Institute at the University of Utah

- Scientists at Huntsman Cancer Institute (HCI) at the University of Utah (U of U), in collaboration with the Salk Institute for Biological Studies, have generated the first single cell resolution atlas of genes that control the formation of breast tissue. The atlas provides a comprehensive molecular map that will be used to help researchers understand how breast cancers form and to pinpoint new ways to prevent, diagnose, and treat the disease.

Released:
7-Aug-2018 11:00 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites

Article ID: 698627

Solid Tumors Targeted in New CAR T-Cell Immunotherapy Trial

Seattle Children's Hospital

Seattle Children’s has opened a chimeric antigen receptor (CAR) T-cell immunotherapy trial for children and young adults with relapsed or refractory non-central nervous system EGFR-expressing solid tumors. In the phase 1 trial, STRIvE-01, cancer-fighting CAR T cells will target the EGFR protein expressed in many childhood sarcoma, kidney and neuroblastoma tumors.

Released:
7-Aug-2018 10:35 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 698638

Announcing the TCT 2018 Late-Breaking Trials

Cardiovascular Research Foundation (CRF)

The Cardiovascular Research Foundation (CRF) has announced the 15 late-breaking trials and 12 late-breaking clinical science presentations that will be reported at the Transcatheter Cardiovascular Therapeutics (TCT) 2018 scientific symposium. TCT, the world’s premier educational meeting specializing in interventional cardiovascular medicine, will take place September 21 – 25, 2018 at the San Diego Convention Center in San Diego, California.

Released:
7-Aug-2018 10:35 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Showing results

4150 of 2527





Chat now!